Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.38 - $22.5 $380 - $22,500
1,000 New
1,000 $0
Q3 2021

Nov 05, 2021

SELL
$2.8 - $3.72 $2,800 - $3,720
-1,000 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$2.61 - $4.17 $2,610 - $4,170
1,000 New
1,000 $3,000
Q1 2021

May 24, 2021

SELL
$2.91 - $4.32 $16,351 - $24,274
-5,619 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$2.15 - $3.5 $9,070 - $14,766
4,219 Added 301.36%
5,619 $15,000
Q3 2020

Nov 16, 2020

BUY
$2.77 - $6.17 $3,878 - $8,638
1,400 New
1,400 $4,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.